These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37425258)

  • 1. Assessment of interleukin-10 promoter variant (-1082A/G) and cytokine production in patients with hemolytic uremic syndrome.
    Mongelos MA; Sosa FN; Pineda GE; Fiorentino G; Santiago A; Abelleyro MM; Rossetti LC; Exeni R; De Brasi CD; Palermo MS; Ramos MV
    Front Pediatr; 2023; 11():1210158. PubMed ID: 37425258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Ramos MV; Mejias MP; Sabbione F; Fernandez-Brando RJ; Santiago AP; Amaral MM; Exeni R; Trevani AS; Palermo MS
    J Innate Immun; 2016; 8(4):400-11. PubMed ID: 27230920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab7b participation on the TLR4 (Toll-like receptor) endocytic pathway in Shiga toxin-associated Hemolytic Uremic Syndrome (HUS).
    Lafalla Manzano AF; Gil Lorenzo AF; Bocanegra V; Costantino VV; Cacciamani V; Benardon ME; Vallés PG
    Cytokine; 2019 Sep; 121():154732. PubMed ID: 31153054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
    Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
    BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production is altered in monocytes from children with hemolytic uremic syndrome.
    Fernández GC; Ramos MV; Landoni VI; Bentancor LV; Fernández-Brando RJ; Exeni R; Laso Mdel C; Exeni A; Grimoldi I; Isturiz MA; Palermo MS
    J Clin Immunol; 2012 Jun; 32(3):622-31. PubMed ID: 22228570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.
    Guirro M; Piazza RM; de Souza RL; Guth BE
    BMC Infect Dis; 2014 Jun; 14():320. PubMed ID: 24919599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS.
    Shimizu M
    Pediatr Int; 2020 Mar; 62(3):308-315. PubMed ID: 31742829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome.
    Lipiec K; Adamczyk P; Świętochowska E; Ziora K; Szczepańska M
    Adv Clin Exp Med; 2018 Jul; 27(7):955-962. PubMed ID: 29905409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic
    Tasaki Y; Inoue N; Shimizu M; Sugimoto N; Ishikawa S; Mizuta M; Yokoyama T; Kuroda M; Ohta K; Yachie A; Wada T
    Ren Fail; 2021 Dec; 43(1):382-387. PubMed ID: 33641616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome.
    Chang HJ; Kim HY; Choi JH; Choi HJ; Ko JS; Ha IS; Cheong HI; Choi Y; Kang HG
    Korean J Pediatr; 2014 Feb; 57(2):96-9. PubMed ID: 24678335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inflammatory cytokine levels in hemolytic uremic syndrome.
    Litalien C; Proulx F; Mariscalco MM; Robitaille P; Turgeon JP; Orrbine E; Rowe PC; McLaine PN; Seidman E
    Pediatr Nephrol; 1999 Nov; 13(9):840-5. PubMed ID: 10603133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.